Evaluation of adjunct immunohistochemistry on reporting patterns of non-small cell lung carcinoma diagnosed histologically in a regional pathology centre

Journal of Clinical Pathology

Volumn 64, Issue 12, 2011, Pages 1136-1138

  McLean, E C ^a   Monaghan, H ^a   Salter, D M ^a   Wallace, W A ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CELL TYPE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATHOLOGIST; PRIORITY JOURNAL;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MEDICAL AUDIT;

EID: 81855194021     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2011.090571     Document Type: Article

References (12)

1. Travis WD, Brambilla E, Muller-Hermelink HK, et al., eds. World Health Organisation Classifiaction of Tumours. Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
2. Wallace WA. The challenge of classifying poorly differentiated tumours in the lung. Histopathology 2009;54:28-42.
3. Thomas JS, Lamb D, Ashcroft T, et al. How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung cancer Working Party. Thorax 1993;48:1135-9. (Pubitemid 23336832)
4. Stinchcombe TE, Grilley-Olson JE, Socinski MA. If histology matters.... J Clin Oncol 2010;11:1810-12.
5. Edwards SL, Roberts C, McKean ME, et al. Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category. J Clin Pathol 2000;53:537-40. (Pubitemid 30432112)
6. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cispaltin plus pemetrexed in chemotherapy-naïve patients with advanced-stage non-small cell lung cancer. J Clin Oncol 2008;26:3543-51.
7. Loo PS, Thomas SC, Nicholson MC, et al. Subtyping of undifferentiated non-small cell carcinoma in bronchial biopsy specimens. J Thorac Oncol 2010;5:442-7.
8. Travis WD, Brambilla E, Noguchi M, et al. International association for the stuy of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85.
9. Wallace WA, Rassl DM. Accuracy of Cell Typing in Non-Small Cell Lung Cancer by EBUS/EUS - FNA Cytology Samples. Eur Respir J 2011;38:911-7.
10. Righi L, Graziano P, Fornari A, et al. Immunohistochemical subtyping of non-small cell lung cancer not otherwise specified in fine needle aspiration cytology: a retrospective study of 103 cases with surgical correlation. Cancer 2011;117:3416-23.
11. Nicholson AG, Gonzalez D, Shah P, et al. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytological material using a panel of mucin staining, TTF1, cytokeratin 5/6 and p63 and EGFR mutation analysis. J Thorac Oncol 2010;5:436-41.
12. Terry J, Leung S, Laskin J, et al. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumour samples. Am J Surg Pathol 2010;34:1805-11.